# clm_CC42DDED77FE

subject: Merck & Co. (/record/merck.md)  
predicate: quarterly_research_and_development  
value: 12,592,000,000 United States dollar  
valid_from: 2026-03-31  
valid_to: 2026-06-30  
published: 2026-05-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_6963A9FE29D9  
last_updated: 2026-11-08  
cite: AsOf. "Merck & Co. quarterly research and development: 12,592,000,000 United States dollar", as of 2026-03-31 (until 2026-06-30). Claim clm_CC42DDED77FE, https://asof.is/claim/clm_CC42DDED77FE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2026, filed 2026-05-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm (primary, SEC EDGAR 10-Q Q1 FY2026, published 2026-05-04)

## Supersedes

- [Merck & Co.](/record/merck.md) | quarterly_research_and_development | 4,234,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_CC42DDED77FE](/claim/clm_CC42DDED77FE.md) | [clm_E7C205B81C1E](/claim/clm_E7C205B81C1E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.